World Health Organization. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer. (2024).
International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. https://gco.iarc.fr/today/en/data-sources-methods#mortality. (2022).
Marko, A. J. et al. Targeted nanoparticles for fluorescence imaging of folate receptor positive tumors. Biomolecules 10, 1–12 (2020).
Google ScholarÂ
Hsu, J. C. et al. Nanomaterial-based contrast agents. Nat. Rev. Methods Prim. 3, 30 (2023).
Google ScholarÂ
Fauzia, R. P. et al. Effect of size, charge, and surface functionalization of gadolinium nanoparticles on biocompatibility and cellular uptake as magnetic resonance imaging contrast agents. Trends Sci. 22, 9330–9330 (2025).
Google ScholarÂ
Ahmad, M. Y. et al. Functionalized lanthanide oxide nanoparticles for tumor targeting, medical imaging, and therapy. Pharmaceutics 13, 1890 (2021).
Google ScholarÂ
Gayathri, T., Sundaram, N. M. & Kumar, R. A. Gadolinium oxide nanoparticles for Magnetic Resonance Imaging and cancer theranostics. J. Bionanosci. 9, 409–423 (2015).
Google ScholarÂ
Zhang, T. et al. Facile synthesis of holmium-based nanoparticles as a CT and MRI dual-modal imaging for cancer diagnosis. Front Oncol 11, 741383 (2021).
Google ScholarÂ
Katal, S., Eibschutz, L. S., Saboury, B., Gholamrezanezhad, A. & Alavi, A. Advantages and applications of total-body PET scanning. Diagnostics 12, 426 (2022).
Google ScholarÂ
Wu, J. & Liu, C. Recent advances in cardiac SPECT instrumentation and imaging methods. Phys. Med. Biol. 64, 06TR01 (2019).
Google ScholarÂ
Rahmani, A. A., Jia, Q., Bahti, H. H., Fauzia, R. P. & Wyantuti, S. Recent advances in lanthanide-based nanoparticle contrast agents for magnetic resonance imaging: Synthesis, characterization, and applications. OpenNano 21, 100226 (2025).
Google ScholarÂ
Lacerda, S. Targeted contrast agents for molecular MRI. Inorganics 6(4), 129 (2018).
Google ScholarÂ
Babić-Stojić, B. et al. Gd2O3 nanoparticles stabilized by hydrothermally modified dextrose for positive contrast magnetic resonance imaging. J. Magn. Magn. Mater 403, 118–126 (2016).
Google ScholarÂ
Chowdhury, M. A. Metal-organic-frameworks for biomedical applications in drug delivery, and as MRI contrast agents. J. Biomed. Mater. Res. Part A 105, 1184–1194 (2017).
Google ScholarÂ
Mortezazadeh, T. et al. In vitro and in vivo characteristics of doxorubicin-loaded cyclodextrine-based polyester modified gadolinium oxide nanoparticles: a versatile targeted theranostic system for tumour chemotherapy and molecular resonance imaging. J. Drug Target 28, 533–546 (2020).
Google ScholarÂ
Mortezazadeh, T. et al. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies. Magn. Reson. Mater. Phys., Biol. Med. 32, 487–500 (2019).
Google ScholarÂ
Hussein, F. A., Joe, I. H. & Al-Musawi, S. Investigation of dextran-coated magnetic nanoparticles encapsulated by medication and modified with folate for targeted drug delivery: Invitro and docking studies. Mater. Chem. Phys. 321, 129446 (2024).
Google ScholarÂ
Alnasraui, A. H. F., Joe, I. H. & Al-Musawi, S. Investigation of folate-functionalized magnetic-gold nanoparticles based targeted drug delivery for liver: In vitro in vivo and docking studies. ACS Biomater. Sci. Eng. 10(10), 6299–6313 (2024).
Google ScholarÂ
Difonzo, M., Fliedel, L., Mignet, N., Andrieux, K. & Alhareth, K. How could nanomedicine improve the safety of contrast agents for mri during pregnancy?. Science 4(1), 11 (2022).
Google ScholarÂ
Kostevšek, N. A review on the optimal design of magnetic nanoparticle-based T 2 MRI contrast agents. Magnetochemistry 6(1), 11 (2020).
Google ScholarÂ
Jeon, M., Halbert, M. V., Stephen, Z. R. & Zhang, M. Iron oxide nanoparticles as T1 contrast agents for magnetic resonance imaging: fundamentals, challenges, applications, and prospectives. Adv. Mater. 33, 1906539 (2021).
Google ScholarÂ
Salehipour, M. et al. Recent advances in polymer-coated iron oxide nanoparticles as magnetic resonance imaging contrast agents. J. Nanoparticle Res. 23(2), 48 (2021).
Google ScholarÂ
Gómez-González, E. et al. Lanthanide vanadate-based nanoparticles as multimodal T1–T2 MRI contrast agent and NIR luminescent imaging probe. J. Alloys Compounds 1003, 175647 (2024).
Google ScholarÂ
Gómez-González, E., Núñez, N. O., Caro, C., Garcia-MartÃn, M. L. & Ocaña, M. Carboxylate functionalized NaDy(MoO4)2 nanoparticles with tunable size and shape as high magnetic field MRI contrast agents. J Colloid Interface Sci 629, 310–321 (2023).
Google ScholarÂ
Gómez-González, E. et al. Holmium phosphate nanoparticles as negative contrast agents for high-field magnetic resonance imaging: Synthesis, magnetic relaxivity study and in vivo evaluation. J Colloid Interface Sci 587, 131–140 (2021).
Google ScholarÂ
Akhtar, M. J., Ahamed, M. & Alhadlaq, H. Gadolinium oxide nanoparticles induce toxicity in human endothelial huvecs via lipid peroxidation, mitochondrial dysfunction and autophagy modulation. Nanomaterials 10, 1–18 (2020).
Google ScholarÂ
Ho, S. L. et al. Mono and multiple tumor-targeting ligand-coated ultrasmall gadolinium oxide nanoparticles: enhanced tumor imaging and blood circulation. Pharmaceutics 14(7), 1458 (2022).
Google ScholarÂ
Miao, X. et al. Ultrasmall Gd2O3 nanoparticles surface-coated by polyacrylic acid (PAA) and their PAA-size dependent relaxometric properties. Appl. Surf. Sci. 477, 111–115 (2019).
Google ScholarÂ
Wu, C. et al. Hyaluronic acid-functionalized gadolinium oxide nanoparticles for magnetic resonance imaging-guided radiotherapy of tumors. Nanoscale Res. Lett. 15(1), 94 (2020).
Google ScholarÂ
Jang, Y. J. et al. Hydrophilic biocompatible poly(Acrylic acid-co-maleic acid) polymer as a surface-coating ligand of ultrasmall Gd2O3 nanoparticles to obtain a high R1 value and T1 Mr images. Diagnostics 11, 2 (2021).
Google ScholarÂ
Behzadi, A. H., Zhao, Y., Farooq, Z. & Prince, M. R. Immediate allergic reactions to gadolinium-based contrast agents: A systematic review and meta-analysis. Radiology 286(2), 471–482 (2018).
Google ScholarÂ
Ramalho, J., Ramalho, M., Jay, M., Burke, L. M. & Semelka, R. C. Gadolinium toxicity and treatment. Magn. Reson. Imaging 34, 1394–1398 (2016).
Google ScholarÂ
Han, X., Xu, K., Taratula, O. & Farsad, K. Applications of nanoparticles in biomedical imaging. Nanoscale 11, 799–819 (2019).
Google ScholarÂ
Marasini, S. et al. A novel paramagnetic nanoparticle T2 magnetic resonance imaging contrast agent with high colloidal stability: polyacrylic acid-coated ultrafine dysprosium oxide nanoparticles. Bull. Korean Chem. Soc. 41, 829–836 (2020).
Google ScholarÂ
Yue, H. et al. New class of efficient t2 magnetic resonance imaging contrast agent: Carbon-coated paramagnetic dysprosium oxide nanoparticles. Pharmaceuticals 13, 1–17 (2020).
Google ScholarÂ
Setiawan, H. et al. Synthesis and characterization of gadolinium nanoparticles using polyol method as a candidate for MRI contrast agent. J. Phys. 2193, 12010 (2022).
Tee, J. K. et al. Nanoparticles’ interactions with vasculature in diseases. Chem. Soc. Rev. 48, 5381–5407 (2019).
Google ScholarÂ
Babayevska, N. et al. Functionalized multimodal ZnO@ Gd2O3 nanosystems to use as perspective contrast agent for MRI. Appl. Surf. Sci. 404, 129–137 (2017).
Google ScholarÂ
Bolaños, K., Kogan, M. J. & Araya, E. Capping gold nanoparticles with albumin to improve their biomedical properties. Int. J. Nanomed. 14, 6387–6406 (2019).
Google ScholarÂ
Fatima, A. et al. Recent advances in gadolinium based contrast agents for bioimaging applications. Nanomaterials 11(9), 2449 (2021).
Google ScholarÂ
Smith, L., Byrne, H. L., Waddington, D. & Kuncic, Z. Nanoparticles for MRI-guided radiation therapy: A review. Cancer Nanotechnol. 13(1), 38 (2022).
Google ScholarÂ
Du, J. et al. Folic acid functionalized gadolinium-doped carbon dots as fluorescence / magnetic resonance imaging contrast agent for targeted imaging of liver cancer. Colloids Surf. B Biointerfaces 234, 113721 (2024).
Google ScholarÂ
Zhao, Y., Cui, C., Zhan, J. & Xuan, G. Study of folate receptor-targeted macromolecular gadolinium complex tumor contrast agent. Mater. Today Commun. 33, 104988 (2022).
Google ScholarÂ
Bellotti, E. et al. Targeting cancer cells overexpressing folate receptors with new terpolymer-based nanocapsules: Toward a novel targeted dna delivery system for cancer therapy. Biomedicines 9(9), 1275 (2021).
Google ScholarÂ
Movileanu, C. et al. Folic acid-decorated PEGylated magnetite nanoparticles as efficient drug carriers to tumor cells overexpressing folic acid receptor. Int J Pharm 625, 122064 (2022).
Google ScholarÂ
Zhang, H. et al. Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer. J. Ovarian Res. 9(1), 19 (2016).
Google ScholarÂ
Angelopoulou, A., Kolokithas-Ntoukas, A., Fytas, C. & Avgoustakis, K. Folic acid-functionalized, condensed magnetic nanoparticles for targeted delivery of doxorubicin to tumor cancer cells overexpressing the folate receptor. ACS Omega 4(26), 22214–22227 (2019).
Google ScholarÂ
Wyantuti, S., Iskandar, J., Fauzia, R. P. & Bahti, H. H. Optimization of hydrothermal synthesis of dysprosium oxide nanoparticles-attached-polyethyleneglycol template using response surface methodology-Box-Behnken. Nano Hybrids Composit. 40, 13–18 (2023).
Google ScholarÂ
Fauzia, R. P. et al. Synthesis and characterization of folic acid-modified polyethylene glycol-coated holmium nanoparticles as targeted magnetic resonance imaging agent candidate. Chin. J. Anal. Chem. 53(1), 100478 (2025).
Google ScholarÂ
Dolai, J., Mandal, K. & Jana, N. R. Nanoparticle size effects in biomedical applications. ACS Appl. Nano Mater. 4, 6471–6496 (2021).
Google ScholarÂ
Pochapski, D. J., Carvalho dos Santos, C., Leite, G. W., Pulcinelli, S. H. & Santilli, C. V. Zeta potential and colloidal stability predictions for inorganic nanoparticle dispersions: Effects of experimental conditions and electrokinetic models on the interpretation of results. Langmuir 37(45), 13379–13389 (2021).
Google ScholarÂ
Elbatanony, R. S. et al. Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy. Drug Deliv. Transl. Res. 11, 927–943 (2021).
Google ScholarÂ
Zairov, R. et al. Hydration number: crucial role in nuclear magnetic relaxivity of Gd (III) chelate-based nanoparticles. Sci. Rep. 7(1), 14010 (2017).
Google ScholarÂ
Mahmoud, N. N., Aqabani, H., Hikmat, S. & Abu-Dahab, R. Colloidal stability and cytotoxicity of polydopamine-conjugated gold nanorods against prostate cancer cell lines. Molecules 26(5), 1299 (2021).
Google ScholarÂ
Bhattacharjee, S. DLS and zeta potential – What they are and what they are not?. J. Control. Release 235, 337–351 (2016).
Google ScholarÂ
Nguyenova, H. Y. et al. Stability and biological response of PEGylated gold nanoparticles. Heliyon 10, (2024).
Moore, T. L. et al. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem. Soc. Rev. 44, 6287–6305 (2015).
Google ScholarÂ
Midekessa, G. et al. Zeta potential of extracellular vesicles: Toward understanding the attributes that determine colloidal stability. ACS Omega 5, 16701–16710 (2020).
Google ScholarÂ
Strojan, K. et al. Dispersion of nanoparticles in different media importantly determines the composition of their protein corona. PLoS ONE 12(1), e0169552 (2017).
Google ScholarÂ
Chaturvedi, A. et al. In vitro and ex vivo relaxometric properties of ethylene glycol coated gadolinium oxide nanoparticles for potential use as contrast agents in magnetic resonance imaging. J. Appl. Phys. 128, 034903 (2020).
Google ScholarÂ
Ahmad, M. Y. et al. In vivo positive magnetic resonance imaging applications of poly (methyl vinyl ether-alt-maleic acid)-coated ultra-small paramagnetic gadolinium oxide nanoparticles. Molecules 25(5), 1159 (2020).
Google ScholarÂ
Marasini, S. et al. Polyaspartic acid-coated paramagnetic gadolinium oxide nanoparticles as a dual-modal t1 and t2 magnetic resonance imaging contrast agent. Appl. Sci. 11(17), 8222 (2021).
Google ScholarÂ
Zare, Y. et al. Synthesis and characterization of folate-functionalized silica-based materials and application for bioimaging of cancer cells. Heliyon 9, e13207 (2023).
Google ScholarÂ
Gorle, S., Ariatti, M. & Singh, M. Novel serum-tolerant lipoplexes target the folate receptor efficiently. Eur. J. Pharm. Sci. 59, 83–93 (2014).
Google ScholarÂ
Mallik, R. et al. Folate receptor targeting Mn (II) complex encapsulated porous silica nanoparticle as an MRI contrast agent for early-state detection of cancer. Small 21(7), 2401787 (2025).
Google ScholarÂ
Monteiro, C. A. et al. Evaluating internalization and recycling of folate receptors in breast cancer cells using quantum dots. J. Photochem. Photobiol. B: Biol. 209, 111918 (2020).
Google ScholarÂ
Siwowska, K., Schmid, R. M., Cohrs, S., Schibli, R. & Müller, C. Folate receptor-positive gynecological cancer cells: In vitro and in vivo characterization. Pharmaceuticals 10(3), 72 (2017).
Google ScholarÂ
Bandara, N. A., Hansen, M. J. & Low, P. S. Effect of receptor occupancy on folate receptor internalization. Mol. Pharm. 11, 1007–1013 (2014).
Google ScholarÂ
Daniele, R. et al. Influence of folate-targeted gold nanoparticles on subcellular localization and distribution into lysosomes. Pharmaceutics 15(3), 864 (2023).
Google ScholarÂ
Yang, H. et al. Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism. Int. J. Nanomedicine 6, 2023–2032 (2011).
Google ScholarÂ
Paulos, C. M., Reddy, J. A., Leamon, C. P., Turk, M. J. & Low, P. S. Ligand binding and kinetics of folate receptor recycling in vivo: Impact on receptor-mediated drug delivery. Mol. Pharmacol. 66, 1406–1414 (2004).
Google ScholarÂ
Kawassaki, R. K. et al. Novel gadolinium-free ultrasmall nanostructured positive contrast for magnetic resonance angiography and imaging. Nano Lett. 23, 5497–5505 (2023).
Google ScholarÂ
Samhadaneh, D. M. et al. Evaluation of lanthanide-doped upconverting nanoparticles for in vitro and in vivo applications. ACS Appl. Bio. Mater. 3, 4358–4369 (2020).
Google ScholarÂ
